NCT00360217View on ClinicalTrials.gov

The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

May 31, 2007

Conditions
Hypertriglyceridemia (TG>200<500)HyperlipidemiaCoronary Artery DiseaseCoronary Risk EquivalentDiabetes
Interventions
DRUG

docosahexanoic acid (DHA)

Trial Locations (1)

04074

Maine Center for Lipids and Cardiovascular Health, Scarborough

All Listed Sponsors
lead

Maine Center for Lipids and Cardiovascular Health

OTHER

NCT00360217 - The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes | Biotech Hunter | Biotech Hunter